Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Kapoor, R; Ho, PR; Campbell, N; Chang, I; Deykin, A; Forrestal, F; Lucas, N; Yu, B; Arnold, DL; Freedman, M; Goldman, MD; Hartung, HP; Kubala Havrdova, E; Jeffery, D; Miller, A; Sellebjerg, F; Cadavid, D; Mikol, D; Steiner, D
- المصدر:
The Lancet. Neurology. 17(5):405-415
- الموضوع:
- الدخول الالكتروني :
No Comments.